Agilon Health Inc. (AGL) Misses Q2 EPS by 14c

Agilon Health Inc. (NYSE: AGL) reported Q2 EPS of ($0.25), $0.14 worse than the analyst estimate of ($0.11). Revenue for the quarter came in at $1.4 billion versus the consensus estimate of $1.47 billion.

For earnings history and earnings-related data on Agilon Health Inc. (AGL) click here.

You May Also Be Interested In

• Musalem: strong growth and investment influencing bond market - CNBC
• China semiconductor equipment imports grow 9% in July, Barclays comments
• Barclays reports U.S. hotel revenue per room up 8.2% in July